T
TG Therapeutics, Inc. (TGTX)
NCM – Real Time Price. Currency in USD
42.54
-0.60 (-1.39%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
42.54
-0.60 (-1.39%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.81 | 6.05 | 10 | |
| Quick ratio | 5.12 | 5.63 | 10 | |
| Debt to Equity | 1.29 | 0.30 | 5.0 | |
| Debt to Assets | 0.49 | 1.04 | 5.0 | |
| Interest coverage | 4.54 | -16.91 | 10 | |
| Weighted average score | 8.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3M | 234M | 329M | 616M | 700M |
| Gross Profit | 2M | 219M | 290M | 516M | 582M |
| Operating Income | -193M | 21M | 42M | 123M | 149M |
| Net Income | -198M | 13M | 23M | 447M | 462M |
| EBITDA | -192M | 21M | 42M | 125M | 151M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 60.5 | 100 | 10 |
| Next quarter | 49.45 | -85.24 | 5.5 |
| Current year | 51.76 | -52.93 | 5.5 |
| Next year | 30.65 | 97.89 | 10 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 6.41 | -14.14 | -14.28 | -191.58 | 2.0 |
| Y/Y | 69.56 | 290.85 | 300 | 37.56 | 10 |
| 3y average | 2806.05 | 667.77 | 639.83 | 30.49 | 10 |
| 5y average | 2532.09 | 404.35 | 391.06 | 18.84 | 9.8 |
| Weighted average score | 8.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $753.6M significantly exceeds cash reserves ($442.2M), raising financial stability concerns
Total current assets $1.1B exceed Total current liabilities $187.1M, highlighting excellent liquidity
Debt-to-equity ratio (1.3) is near the industry average, reflecting balanced leverage
Interest coverage ratio (5x) indicates the company easily manages its debt payments
Negative free cash flow -$17.9M limits the company's ability to reinvest or pay down debt